慢性硬膜下血肿(chronic subdural hematoma, CSDH)是桥静脉撕裂所致,常发生于50岁以上老人,可无明确或仅轻微头部外伤史,有的患者合并出血性疾病。目前手术治疗的方式主要包括钻孔冲洗引流术、内镜下血肿清除术、开颅血肿清除术及脑膜中动脉栓塞术。近年来对于CSDH术后复发原因的研究越来越多,据统计,CSDH术后的复发率达2.5%~33%。最近,对使用纤维蛋白溶解剂作为外科治疗的辅助手段来解决血肿复发问题的相关研究逐渐增加。有研究发现在CSDH术后患者中应用尿激酶可预防血肿复发。常规鞘内应用尿激酶和组织型纤溶酶原激活剂可能是治疗慢性硬膜下血肿的新方向。然而,缺乏确凿的临床证据,需要进一步的前瞻性对照研究来证实这种治疗策略的益处和安全性,并确定最佳的药物和剂量方案。
Chronic subdural hematoma (CSDH) is caused by the tear of the bridging vein, and it often occurs in the elderly over 50 years old. There may be no clear history of or only minor head trauma, and some patients are complicated by bleeding diseases. The current surgical treatment methods mainly in-clude drilling irrigation and drainage, endoscopic hematoma evacuation, craniotomy hematoma evacuation and middle meningeal artery embolization. In recent years, more and more studies have been conducted on the reasons for recurrence after CSDH surgery. According to statistics, the re-currence rate after CSDH surgery is 2.5%~33%. Recently, there has been an increase in the use of fibrinolytic agents as an adjunct to surgical treatment to address hematoma recurrence. Studies have found that the application of urokinase in patients after CSDH can prevent hematoma recur-rence. Routine intrathecal application of urokinase and tissue plasminogen activator may be a new direction for the treatment of chronic subdural hematoma. However, conclusive clinical evidence is lacking and further prospective controlled studies are needed to confirm the benefit and safety of this treatment strategy and to determine the optimal drug and dosage regimen.
2Department of Neurosurgery, The Affiliated Hospital of Qinghai University, Xining Qinghai
Received: Apr. 9th, 2022; accepted: May 3rd, 2022; published: May 11th, 2022
ABSTRACT
Chronic subdural hematoma (CSDH) is caused by the tear of the bridging vein, and it often occurs in the elderly over 50 years old. There may be no clear history of or only minor head trauma, and some patients are complicated by bleeding diseases. The current surgical treatment methods mainly include drilling irrigation and drainage, endoscopic hematoma evacuation, craniotomy hematoma evacuation and middle meningeal artery embolization. In recent years, more and more studies have been conducted on the reasons for recurrence after CSDH surgery. According to statistics, the recurrence rate after CSDH surgery is 2.5%~33%. Recently, there has been an increase in the use of fibrinolytic agents as an adjunct to surgical treatment to address hematoma recurrence. Studies have found that the application of urokinase in patients after CSDH can prevent hematoma recurrence. Routine intrathecal application of urokinase and tissue plasminogen activator may be a new direction for the treatment of chronic subdural hematoma. However, conclusive clinical evidence is lacking and further prospective controlled studies are needed to confirm the benefit and safety of this treatment strategy and to determine the optimal drug and dosage regimen.
任向荣,李坤正. 慢性硬膜下血肿复发的研究进展Research Progress on Recurrence of Chronic Subdural Hematoma[J]. 临床医学进展, 2022, 12(05): 3805-3812. https://doi.org/10.12677/ACM.2022.125549
参考文献ReferencesHan, M.H., il Ryu, J., Kim, C.H., et al. (2016) Predictive Factors for Recurrence and Clinical Outcomes in Patients with Chronic Subdural Hematoma. Journal of Neurosurgery, 127, 1117-1125.
<br>https://doi.org/10.3171/2016.8.JNS16867Ayub, K. and Yarnell, O.P. (1969) Subdural Haematoma after Whiplash Injury. The Lancet, 294, 237-239.
<br>https://doi.org/10.1016/S0140-6736(69)90005-1Markwalder, T.M. (1981) Chronic Subdural Hematomas: A Review. Journal of Neurosurgery, 54, 637-645.
<br>https://doi.org/10.3171/jns.1981.54.5.0637Inglis, K. (1946) Subdural Haemorrhage, Cysts and False Mem-branes: Illustrating the Influence of Intrinsic Factors in Disease When Development of the Body Is Normal. Brain, 69, 157-194. <br>https://doi.org/10.1093/brain/69.3.157Schwartz, A.B. (1916) The Etiology of Pachymeningitis Hemorrhagica Interna in Infants. American Journal of Diseases of Children, 11, 23-32. <br>https://doi.org/10.1001/archpedi.1916.04110070034004Putnam, T.J. and Cushing, H. (1925) Chronic Sub-dural Hematoma: Its Pathology, Its Relation to Pachymeningitis Hemorrhagica and Its Surgical Treatment. Archives of Surgery, 11, 329-393.
<br>https://doi.org/10.1001/archsurg.1925.01120150002001Edlmann, E., Giorgi-Coll, S., Whitfield, P.C., et al. (2017) Pathophysiology of Chronic Subdural Haematoma: Inflammation, Angiogenesis and Implications for Pharma-cotherapy. Journal of Neuroinflammation, 14, 1-13.
<br>https://doi.org/10.1186/s12974-017-0881-yNanko, N., Tanikawa, M., Mase, M., et al. (2009) Involvement of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor in the Mechanism of Development of Chronic Subdural Hematoma. Neurologia Medico- Chirurgica, 49, 379-385. <br>https://doi.org/10.2176/nmc.49.379Ito, H., Komai, T. and Yamamoto, S. (1978) Fibrinolytic Enzyme in the Lining Walls of Chronic Subdural Hematoma. Jour-nal of Neurosurgery, 48, 197-200. <br>https://doi.org/10.3171/jns.1978.48.2.0197Murakami, H., Hirose, Y., Sa-goh, M., et al. (2002) Why Do Chronic Subdural Hematomas Continue to Grow Slowly and Not Coagulate? Role of Thrombomodulin in the Mechanism. Journal of Neurosurgery, 96, 877-884.
<br>https://doi.org/10.3171/jns.2002.96.5.0877Hohenstein, A., Erber, R., Schilling, L., et al. (2005) Increased mRNA Expression of VEGF within the Hematoma and Imbalance of Angiopoietin-1 and-2 mRNA within the Neomem-branes of Chronic Subdural Hematoma. Journal of Neurotrauma, 22, 518-528. <br>https://doi.org/10.1089/neu.2005.22.518Nakagawa, T., Kodera, T. and Kubota, T. (2000) Expression of Ma-trix Metalloproteinases in the Chronic Subdural Haematoma Membrane. Acta Neurochirurgica, 142, 61-66. <br>https://doi.org/10.1007/s007010050008Kwaan, H.C. (1972) Disorders of Fibrinolysis. Medical Clinics of North America, 56, 163-176.
<br>https://doi.org/10.1016/S0025-7125(16)32432-4Fujisawa, H., Ito, H., Saito, K., et al. (1991) Immunohisto-chemical Localization of Tissue-Type Plasminogen Activator in the Lining Wall of Chronic Subdural Hematoma. Surgical Neurology, 35, 441-445.
<br>https://doi.org/10.1016/0090-3019(91)90177-BAgre, P. (2006) The Aquaporin Water Channels. Proceedings of the American Thoracic Society, 3, 5-13.
<br>https://doi.org/10.1513/pats.200510-109JHZelenina, M. (2010) Regulation of Brain Aquaporins. Neuro-chemistry International, 57, 468-488.
<br>https://doi.org/10.1016/j.neuint.2010.03.022Nielsen, S., Nagelhus, E.A., Amiry-Moghaddam, M., et al. (1997) Specialized Membrane Domains for Water Transport in Glial Cells: High-Resolution Immunogold Cytochemistry of Aquaporin-4 in Rat Brain. Journal of Neuroscience, 17, 171-180. <br>https://doi.org/10.1523/JNEUROSCI.17-01-00171.1997Basaldella, L., Perin, A., Orvieto, E., et al. (2010) A Preliminary Study of Aquaporin 1 Immunolocalization in Chronic Subdural Hematoma Membranes. Journal of Clinical Neuroscience, 17, 905-907.
<br>https://doi.org/10.1016/j.jocn.2009.11.010Utsuki, S., Oka, H., Kijima, C., et al. (2012) Role of Saireito in Postoperative Chronic Subdural Hematoma Recurrence Prevention. Journal of Traditional Medicines, 29, 137-142.Hori, Y.S., Ebisudani, Y., Aoi, M., et al. (2018) Elevated Serum Fibrinogen Degradation Products on Admission Is a Novel Predictive Factor for Recurrence of Chronic Subdural Hematoma. World Neurosurgery, 118, e753-e757.
<br>https://doi.org/10.1016/j.wneu.2018.07.039宗海亮, 许洪升, 何晓光, 尚明. 慢性硬膜下血肿钻颅术并发症的临床研究[J]. 中国继续医学教育, 2021, 13(7): 150-153.Srivatsan, A., Mohanty, A., Nascimento, F.A., et al. (2019) Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Meta-Analysis and Systematic Re-view. World Neurosurgery, 122, 613-619.
<br>https://doi.org/10.1016/j.wneu.2018.11.167Bender, M.B. and Christoff, N. (1974) Nonsurgical Treatment of Subdural Hematomas. Archives of Neurology, 31, 73-79. <br>https://doi.org/10.1001/archneur.1974.00490380021001Pichert, G. and Henn, V. (1987) Conservative Ther-apy of Chronic Subdural Hematomas. Schweizerische Medizinische Wochenschrift, 117, 1856-1862.Sun, T.F.D., Boet, R. and Poon, W.S. (2005) Non-Surgical Primary Treatment of Chronic Subdural Haematoma: Preliminary Results of Using Dexamethasone. British Journal of Neurosurgery, 19, 327-333.
<br>https://doi.org/10.1080/02688690500305332Delgado-López, P.D., Martín-Velasco, V., Castilla-Díez, J.M., et al. (2009) Dexamethasone Treatment in Chronic Subdural Haematoma. Neurocirugia, 20, 346-359. <br>https://doi.org/10.1016/S1130-1473(09)70154-XDran, G., Berthier, F., Fontaine, D., et al. (2007) Effective-ness of Adjuvant Corticosteroid Therapy for Chronic Subdural Hematoma: A Retrospective Study of 198 Cases. Neu-ro-chirurgie, 53, 477-482.
<br>https://doi.org/10.1016/j.neuchi.2007.09.146Thotakura, A.K. and Marabathina, N.R. (2015) Nonsurgical Treatment of Chronic Subdural Hematoma with Steroids. World Neurosurgery, 84, 1968-1972. <br>https://doi.org/10.1016/j.wneu.2015.08.044Qian, Z., Yang, D., Sun, F., et al. (2017) Risk Factors for Recur-rence of Chronic Subdural Hematoma after Burr Hole Surgery: Potential Protective Role of Dexamethasone. British Journal of Neurosurgery, 31, 84-88.
<br>https://doi.org/10.1080/02688697.2016.1260686Hutchinson, P.J., Edlmann, E., Bulters, D., et al. (2020) Trial of Dexamethasone for Chronic Subdural Hematoma. New England Journal of Medicine, 383, 2616-2627. <br>https://doi.org/10.1056/NEJMoa2020473Wang, X., Song, J., He, Q. and You, C. (2021) Pharmacological Treatment in the Management of Chronic Subdural Hematoma. Frontiers in Aging Neuroscience, 13, Article ID: 684501. <br>https://doi.org/10.3389/fnagi.2021.684501Berghauser Pont, L.M.E., Dirven, C.M.F., Dippel, D.W.J., et al. (2012) The Role of Corticosteroids in the Management of Chronic Subdural Hematoma: A Systematic Review. European Journal of Neurology, 19, 1397-1403.
<br>https://doi.org/10.1111/j.1468-1331.2012.03768.xYoussef, S., Stüve, O., Patarroyo, J.C., et al. (2002) The HMG-CoA Reductase Inhibitor, Atorvastatin, Promotes a Th2 Bias and Reverses Paralysis in Central Nervous System Autoimmune Disease. Nature, 420, 78-84.
<br>https://doi.org/10.1038/nature01158Wang, B., Sun, L., Tian, Y., et al. (2012) Effects of Atorvastatin in the Regulation of Circulating EPCs and Angiogenesis in Traumatic Brain Injury in Rats. Journal of the Neurological Scienc-es, 319, 117-123.
<br>https://doi.org/10.1016/j.jns.2012.04.015Li, Z., Wang, B., Kan, Z., et al. (2012) Progesterone Increases Cir-culating Endothelial Progenitor Cells and Induces Neural Regeneration after Traumatic Brain Injury in Aged Rats. Jour-nal of Neurotrauma, 29, 343-353.
<br>https://doi.org/10.1089/neu.2011.1807Araújo, F.A., Rocha, M.A., Mendes, J.B., et al. (2010) Atorvastatin Inhibits Inflammatory Angiogenesis in Mice through Down Regulation of VEGF, TNF-α and TGF-β1. Biomedicine & Pharmacotherapy, 64, 29-34.
<br>https://doi.org/10.1016/j.biopha.2009.03.003Jiang, R., Zhao, S., Wang, R., et al. (2018) Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized Clinical Trial. JAMA Neurology, 75, 1338-1346.
<br>https://doi.org/10.1001/jamaneurol.2018.2030Logan, J.W. (1990) Diet and Free Radicals in Cot Death. New Zealand Medical Journal, 103, 592.Coates, D. (2003) The Angiotensin Converting Enzyme (ACE). The Interna-tional Journal of Biochemistry & Cell Biology, 35, 769-773. <br>https://doi.org/10.1001/jamaneurol.2018.2030Ito, H., Yamamoto, S., Komai, T., et al. (1976) Role of Local Hyperfibrinolysis in the Etiology of Chronic Subdural Hema-toma. Journal of Neurosurgery, 45, 26-31. <br>https://doi.org/10.3171/jns.1976.45.1.0026Weigel, R., Hohen-stein, A., Schlickum, L., et al. (2007) Angiotensin Converting Enzyme Inhibition for Arterial Hypertension Reduces the Risk of Recurrence in Patients with Chronic Subdural Hematoma Possibly by an Antiangiogenic Mechanism. Neurosur-gery, 61, 788-792. <br>https://doi.org/10.3171/jns.1976.45.1.0026Neidert, M.C., Schmidt, T., Mitova, T., et al. (2016) Preoperative Angiotensin Converting Enzyme Inhibitor Usage in Patients with Chronic Subdural Hematoma: As-sociations with Initial Presentation and Clinical Outcome. Journal of Clinical Neuroscience, 28, 82-86. <br>https://doi.org/10.1016/j.jocn.2015.09.022Poulsen, F.R., Munthe, S., Soe, M., et al. (2014) Perindopril and Residual Chronicsubdural Hematoma Volumes Six Weeks after Burr Hole Surgery: A Randomized Trial. Clinical Neu-rology and Neurosurgery, 123, 4-8.
<br>https://doi.org/10.1016/j.clineuro.2014.05.003李逢佳, 李强, 杨红. 钻孔引流术加尿激酶治疗慢性硬膜下血肿96例分析[J]. 中国误诊学杂志, 2010, 10(34): 8472.王安睿, 庄永辉, 戴成国, 等. 微创引流尿激酶血肿腔注射治疗慢性硬膜下血肿66例临床分析[J]. 昆明医学院学报, 2011, 32(9): 57-59.Kostis, W.J., Shetty, M., Chowdhury, Y.S., et al. (2018) ACE Inhibitor-Induced Angioedema: A Review. Current Hypertension Reports, 20, 1-7. <br>https://doi.org/10.1007/s11906-018-0859-x杨舟山, 蔡恩源. 单纯钻孔引流法与钻孔尿激酶注入引流法治疗慢性硬膜下血肿的效果比较[J]. 中国处方药, 2015, 13(1): 106.王进进, 施辉, 董文胜, 樊拥军, 朱家球, 邵世珂. 微创钻孔引流联合尿激酶和阿托伐他汀对慢性硬膜下血肿患者术后神经功能及复发率的影响[J]. 脑与神经疾病杂志, 2021, 29(4): 222-227.王亚飞, 王国伟, 张轩宇, 崔政, 郑虎林, 霍龙伟. 微创硬通道钻孔不冲洗、尿激酶溶解引流联合口服阿托伐他汀治疗慢性硬膜下血肿的临床研究[J]. 川北医学院学报, 2020, 35(5): 898-901.